(MedPage Today) — The FDA granted premarket approval to a gastric balloon system for short-term weight loss alongside lifestyle intervention, developer Allurion announced on Monday.
The drug-free system is indicated for adults 22 to 65 years…
Source link : https://www.medpagetoday.com/endocrinology/obesity/120029
Author :
Publish date : 2026-02-24 22:29:00
Copyright for syndicated content belongs to the linked Source.
